FindTrial
Sign In

It is a Comparative Clinical study To Evaluate The Efficacy of Guduchi Tail Matrabasti As Addo On Therapy With Antigout Drug In Gout.

A Comparative Clinical Trial To Evaluate The Efficacy of Guduchi Tail Matrabasti As Add On Therapy With Antigout Drug In Gout. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102772
Enrollment
90
Registered
2026-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M258- Other specified joint disorders

Interventions

None listed

Sponsors

DIPALI KUNDALWAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age:20 65years. 2. Sex:Both male and female. 3. Socio Economic status: All 4. Patients of Gout presenting features as per text such as swelling, pain, stiffness, tenderness, Discolouration of skin.

Exclusion criteria

Exclusion criteria: Age below 20 and above 65 years. Arthropathy other than Gout.Leprosy,SLE,Sarvang shoth,TB,Renal disease. Pregnancy and lactating mother.

Design outcomes

Primary

MeasureTime frame
To decrease the uric acid level in gout after giving Guduchi Tail Matrabasti with Antigout Drug allopurinol for 15 daysTimepoint: 0th day before trial, 15th day after trial and 30th day on day of follow up—

Secondary

MeasureTime frame
NILTimepoint: Nil—

Countries

India

Contacts

Public ContactManjusha Sunil More

professor

manjushasunilmore@gmail.com9422766836

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026